Healthcare Providers and Services
Company Overview of Vansen Pharma Inc.
Vansen Pharma Inc. is engaged in the sale and marketing of specialty pharmaceutical products in the United States. It sells Spectracef, an anti-infective product and its cefditoren pivoxil generic product to wholesalers and pharmacy chains; and FACTIVE tablets for the treatment of acute bacterial exacerbation of chronic bronchitis and mild to moderate community-acquired pneumonia. The company was formerly known as Okana Ventures, Inc. and changed its name to Vansen Pharma Inc. in August 2013. Vansen Pharma Inc. was founded in 2005 and is based in Vancouver, Canada.
666 Burrard Street
Vancouver, BC V6C 3P6
Founded in 2005
Key Executives for Vansen Pharma Inc.
Vansen Pharma Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|2275518 Ontario Inc.||Americas|
|3284733 Nova Scotia Limited||Americas|
|3958230 Canada, Inc.||Americas|
|682202 B.C. Ltd.||Americas|
|729759 Alberta Ltd||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Vansen Pharma Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.